Scarica l'app Stockscreener
5.485
1.01%
0.055
Cytek Biosciences Inc Azioni (CTKB) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
9.07%
48.14
|
44.13 | 62.14 | 52.29 | 45.60 |
| Cost Of Revenue |
13.47%
19.80
|
22.88 | 29.26 | 24.74 | 21.73 |
| Gross Profit |
33.34%
28.34
|
21.25 | 32.88 | 27.55 | 23.87 |
| Operating Expenses |
0.06%
39.74
|
39.72 | 38.48 | 36.74 | 34.49 |
| Operating Income/Loss |
38.25%
-11.40
|
-18.46 | -5.594 | -9.192 | -10.62 |
| Nonoperating Income/Loss |
122.29%
-0.243
|
1.09 | 1.563 | 1.423 | 3.849 |
| Income Tax Expense/Benefit, Deferred |
100.00%
-
|
-0.183 | 38.58 | -2.627 | -2.056 |
| Income Tax Expense/Benefit |
65.51%
0.515
|
1.493 | 40.05 | -2.291 | -1.192 |
Net Income/Loss
|
35.56%
-12.16
|
-18.87 | -44.08 | -5.478 | -5.583 |
| Basic Average Shares |
0.59%
129.46
|
128.70 | 0.1416 | 127.55 | 126.93 |
| Diluted Average Shares |
0.59%
129.46
|
128.70 | 0.1416 | 127.55 | 126.93 |
0.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):